Profil
David R.
Speights served as the Chief Executive Officer of Zila, Inc. from 2009 to 2014.
He also worked as a Controller at Atrix Laboratories, Inc.
Ehemalige bekannte Positionen von David R. Speights
| Unternehmen | Position | Ende |
|---|---|---|
Zila, Inc.
 Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Vorstandsvorsitzender | 01.12.2014 |
Atrix Laboratories, Inc.
 Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | Comptroller/Controller/Auditor | 14.02.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Atrix Laboratories, Inc.
Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | Health Technology |
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Health Technology |
